ANACARDIC ACID

ANACARDIC ACID is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 568 references associated with ANACARDIC ACID in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with ANACARDIC ACID

Download all related citations
Per page 10 20 50 100 | Total 125
Authors Title Published Journal PubMed Link
Wisastra R et al. Discovery of a novel activator of 5-lipoxygenase from an anacardic acid derived compound collection. 2013 Bioorg. Med. Chem. pmid:24231650
Wisastra R et al. Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases. 2012 Bioorg. Med. Chem. pmid:22789707
Wu J et al. Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60. 2009 Bioorg. Med. Chem. pmid:19114310
Muroi H et al. Synergistic effects of anacardic acids and methicillin against methicillin resistant Staphylococcus aureus. 2004 Bioorg. Med. Chem. pmid:14738968
Green IR et al. Molecular design of anti-MRSA agents based on the anacardic acid scaffold. 2007 Bioorg. Med. Chem. pmid:17601740
Mamidyala SK et al. Efficient synthesis of anacardic acid analogues and their antibacterial activities. 2013 Bioorg. Med. Chem. Lett. pmid:23416004
Kanojia RM et al. 6-oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systems. 1999 Bioorg. Med. Chem. Lett. pmid:10571153
Hoellein A et al. Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma. 2014 Blood pmid:25143484
Sung B et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. 2008 Blood pmid:18349320
Park M et al. Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway. 2018 BMC Complement Altern Med pmid:29463243

Table of Content